Physician profile
David B Doherty
NPI 1528333770
$14,215.11
in general payments reported to CMS, 2019-2025
10 companies · $627 in 2025
The $627 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $197 · 2021: $340 · 2022: $945 · 2023: $1,361 · 2024: $725 · 2025: $627.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,713.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,712.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $9,881.19 | 2019-2024 | Real Intelligence |
| Stryker Corporation | $2,974.07 | 2019-2025 | Mako, Variax |
| Integrum INC. | $379.41 | 2023-2025 | Opra Implant System |
| Orthalign INC | $286.11 | 2021-2022 | |
| Becton, Dickinson and Company | $182.26 | 2024 | Channel Drain |
| Zimmer Biomet Holdings, INC. | $146.22 | 2022 | |
| Total Joint Orthopedics, INC. | $127.52 | 2019 | |
| Biocomposites INC | $110.82 | 2025 | Stimulan |
| Medtronic, INC. | $88.11 | 2023 | Swiftset |
| Medinc of Texas | $39.40 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Doherty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.